Cardiovascular researcher with strong educational background and demonstrated commercial interest in biotechnology and life sciences industry, acquired through direct working experience as scientific advisor in the R.T. Lee lab at Harvard Medical School (Greater Boston Area) and at Oxbridge Biotech Roundtable. Determined to build trustworthy relationships and achieve pre-defined goals through tenacity, solid communication and negotiation skills. I am skilled in team building dynamics but also comfortable working independently to develop critical and original thinking.

Postdoctoral Research Fellow @ - Responsible for three independent projects and the supervision and managment of three HMS students. - Coordinator of translational medicine projects aimed at commercializing scientific discoveries involving multiple collaborations between the R.T. Lee lab at HMS and international pharmaceutical companies. From March 2014 to Present (1 year 10 months) Greater Boston AreaPh.D. Fellow, British Heart Foundation @ As a BHF Fellow and Ph.D. candidate I focused on a research project in cardiovascular regenerative medicine in the laboratory of Professor Nadia Rosenthal. I worked on the development and optimization of therapeutic approach of cardiac gene and cell delivery in multiple animal and cell models to investigate the effects of the insulin-like growth factor-1Ea (IGF-1Ea) in cardiac pathophysiology. I provided clear indications of the therapeutic potential of this compound. From October 2010 to March 2014 (3 years 6 months) President - London chapter @ Leader of the London team (15 members) to promote knowledge and technology transfer via business consulting internships for post-doctoral professionals in partnership with leader pharmaceutical companies. From January 2013 to September 2013 (9 months) London, United KingdomOneStart biotech competition 2013 @ Logistics coordinator of the world’s largest life sciences and health care business plan accelerator program (final prize US$150K) organized by OBR and SRone, the venture capital arm of GlaxoSmithKline. From January 2013 to May 2013 (5 months) London, United Kingdom

Doctor of Philosophy (Ph.D.), Clinical Medicine Research (National Heart and Lung Institute) @ Imperial College London From 2010 to 2014 MRes Degree & DIC, Biomedical Research - Cardiovascular Science, Technology and Medicine, Distinction @ Imperial College London From 2009 to 2010 Master of Science (MS), Molecular Biology, 110/110 cum laude @ Università degli Studi di Roma Tre From 2006 to 2008 Erasmus exchange programme, Biology, General @ Universidad Complutense de Madrid From 2003 to 2004 Tommaso Ph.D. is skilled in: Tissue Engineering, Western Blotting, PCR, In Vitro, Cell, RT-PCR, In Vivo, Molecular Cloning, Fluorescence Microscopy, DNA, Lifesciences, Biotechnology, Transfection, Life Sciences